Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zolpidem tartrate sublingual for MOTN insomnia
NCT00466193Phase 3Completed
- Sponsor
- Transcept Pharmaceuticals
- Start
- May 2007
- Primary completion
- Nov 2007
- Countries
- 1
01
Overview
A Phase 3 trial of zolpidem sublingual tablet in Insomnia, sponsored by Transcept Pharmaceuticals. Started May 2007; status: completed.
02
Drugs
zolpidem sublingual tablet
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00466193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00466193.